logo

For the Inventor, By the Inventor

Hochheim, Germany

Hans-Ludwig Schäfer

This inventor holds 6 USPTO granted patents. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2001-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hans-Ludwig Schäfer. Retrieved from https://idiyas.com/inventor/hans-ludwig-schandaumlfer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 6

Forward Citations = 186(Granted Patents)


Company Filing History:

goldMedal6 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents

Years Active: 2001-2003

Loading Chart...
6 patents (USPTO):Explore Patents
1. 6624185 - Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals (2003-09-23),
2. 6569835 - Combinations with statin and aryl-substituted propanolamine derivatives, their preparation pharmaceuticals comprising them, and their use (2003-05-27),
3. 6566340 - Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use (2003-05-20),
4. 6451781 - Substituted acylguanidines, process for their preparation, their use as medicaments or diagnostics, and medicaments comprising them (2002-09-17),
5. 6277831 - 1,4-benzothiazepine-1,1-dioxide derivatives substituted by sugar residues, process for their preparation, pharmaceuticals comprising these compounds, and their use (2001-08-21),
6. 6245744 - Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use (2001-06-12),

Title: The Innovations of Hans-Ludwig Schäfer

Introduction

Hans-Ludwig Schäfer is a notable inventor based in Hochheim, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work focuses on the development of innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are groundbreaking inventions such as "Diarylcycloalkyl derivatives, processes for their preparation and their use as pharmaceuticals." Additionally, he has developed "Combinations with statin and aryl-substituted propanolamine derivatives, their preparation pharmaceuticals comprising them, and their use." These patents reflect his commitment to advancing pharmaceutical science.

Career Highlights

Hans-Ludwig Schäfer is currently employed at Aventis Pharma Deutschland GmbH, where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new medications that can improve patient outcomes.

Collaborations

Throughout his career, he has collaborated with esteemed colleagues such as Wendelin Frick and Heiner Glombik. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Hans-Ludwig Schäfer's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…